Phase 4Recruiting
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
Intraoperative Methadone for Postoperative Pain Management in a Head and Neck Oncology Population - A Prospective, Randomized Controlled Trial
- Sponsor
- OHSU Knight Cancer Institute (Academic or other)
- Enrollment
- 58 planned
- Conditions
- Head and Neck Carcinoma; Hypopharyngeal Carcinoma; Laryngeal Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Carcinoma
- Interventions
- Electronic Health Record Review; Fentanyl; Laryngoscopy; Methadone; Surgical Procedure; Survey Administration
- Ages
- adults, older adults
- Registry
- NCT07857655
Full record on ClinicalTrials.gov
From the registry
This phase IV trial compares how well methadone plus standard fentanyl given during surgery (intraoperative) works compared to intraoperative standard fentanyl alone in managing pain after surgery (postoperative) among patients with head and neck cancers. For most head and neck cancers, the standard treatment is surgery to remove the cancer followed by surgical reconstruction, which often requires tissue harvested from another part of the body-known as a "free flap tissue transfer". These procedures are highly complex, demand a two-surgeon team, and often take many hours to complete. The combination of multiple operative sites and extent of the surgery contributes to significant postoperative pain. Methadone is not yet used in the head and neck population but has been utilized in other subspecialties like spine and cardiac surgery. The benefits of methadone may include improved pain control in the first 72 hours postoperatively requiring less opioids postoperatively and improvement in overall pain scores. Giving intraoperative methadone plus standard fentanyl may work better than…
Primary outcomes
- Total morphine milligram equivalents (MMEs) administered in the first 24 hours postoperatively
History
Primary completion expected
Registered
Started